查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1362933

新生兒篩檢市場規模、佔有率、趨勢分析報告：按技術、測試類型、按產品、地區和細分市場預測，2023-2030 年

Newborn Screening Market Size, Share & Trends Analysis Report By Technology (Tandem Mass Spectrometry, Pulse Oximetry), By Test Type, By Product (Instruments, Reagents), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

新生兒篩檢市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球新生兒篩檢市場規模預計將達到 14 億美元。

預計2023年至2030年該市場將以7.54%的年複合成長率擴張。新生兒篩檢市場的成長主要要素有利的報銷政策、政府支持計劃以及專注於開發高效篩檢測試的主要企業的存在所推動的。此外，中國和印度等人口最多的經濟體的高出生率和高可支配所得要素將積極推動市場發展。

根據《2022 年印度兒科報告》，NBS 已成為公共衛生預防的主要內容，其小組也不斷增加。基於 DBS 的特定代謝測試工具在 NBS 中仍然很重要。科學進步使基因和基因組測試成為有效的工具。然而，兩者都有優點和缺點。透過資料和遺傳資料的整合分析，將提高目前NBS對一些遺傳疾病的效率，讓更多罹患的個體得到早期診斷和治療，改善預後。

此外，政府計劃和法律也正在創造促進市場成長的有利環境。世界衛生組織建議實施新生兒篩檢計劃，以保護世界兒童的健康。根據該計劃，日本婦產科學會 (JSOG)、美國衛生與公眾服務部新生兒和兒童遺​​傳疾病部長顧問委員會 (SACHDNC)、英國(PEACH) 和March of Dimes 已經採取了一些政策和舉措。

此外，2022 年 6 月，諾華與美國血液學會建立了戰略合作夥伴關係，以進一步解決六個非洲國家新生兒的鐮狀疾病問題。 ASH 非洲新生兒篩檢聯盟 (CONSA) 在加納、賴比瑞亞、肯亞、奈及利亞、坦尚尼亞、烏幹達和尚比亞等國家的多個地點提供早期療育和篩檢計畫。

此外，對新生兒篩檢領域技術創新的日益關注預計將推動市場成長。例如，2022 年 8 月，Trivitron Healthcare推出了新生兒篩檢、基因組學、分子診斷和代謝組學卓越中心。該工廠將生產基於 ELISA、PCR 和 IVD CE核准的新生兒篩檢試劑盒的癌症標記物。

新生兒篩檢市場報告亮點

  • 按測試類型分類，乾血斑測試領域在 2022 年的整個新生兒篩檢市場中佔據主導地位。在新生兒出生後 24 至 48 小時內用篩檢卡從新生兒腳後跟採集血液，以診斷 50 多種疾病，稱為足跟貼或乾血斑 (DBS) 測試。
  • 從技術來看，串聯質譜技術因其成本效益高、適用性強以及技術升級帶來的高需求，將在2022年佔據整體市場的主導地位。
  • 2022年，亞太地區在新生兒篩檢市場中佔據最大佔有率。基礎設施和醫療保健規劃的改善以及新的擴張機會的可用性預計將在預測期內推動區域市場需求發揮重要作用。
  • 業內公司正在積極尋求策略合作夥伴關係和併購，以確保永續性。例如，Trivitron Healthcare和安捷倫科技公司已經開始在基於LC-MS/MS平台的高精度體外診斷領域合作。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 市場變數、趨勢和範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影響分析

第4章 新生兒篩檢市場：技術分析

  • 新生兒篩檢市場：技術變化分析
  • 串聯質譜法
  • 脈搏血氧儀
  • 基於酵素的測定
  • DNA檢測
  • 電泳
  • 其他

第5章 新生兒篩檢市場：檢測類型分析

  • 新生兒篩檢市場：測試類型變異分析
  • 乾血斑（DBS）測試
  • CCHD
  • 聽力篩檢

第6章 新生兒篩檢市場：產品分析

  • 新生兒篩檢市場：產品變化分析
  • 裝置
  • 試劑

第7章 新生兒篩檢市場：區域分析

  • 2022年及2030年按地區分類的新生兒篩檢市場佔有率
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭形勢

  • 公司分類
  • 策略規劃
  • 2022 年公司市場佔有率分析
  • 公司簡介/名單
    • Covidien Plc.
    • AB SCIEX
    • Bio-Rad Laboratories
    • Agilent Technologies
    • Masimo Corporation
    • Waters Corporation
    • Natus Medical
    • Trivitron Healthcare
    • GE Lifesciences
    • PerkinElmer Inc
Product Code: 978-1-68038-490-1

Newborn Screening Market Growth & Trends:

The global newborn screening market size is expected to reach USD 1.40 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 7.54% from 2023 to 2030. The growth of the market for newborn screening is majorly attributed to favorable reimbursement policies and government support programs, as well as the presence of key players focusing on developing efficient screening tests. In addition, high birth rates in the most populous economies such as China and India, coupled with high disposable income, are factors anticipated to drive the market positively.

According to Indian Paediatrics Report 2022, NBS has become a staple in public health prevention, and its panel is always growing. Specific DBS-based metabolic testing tools continue to be crucial in NBS. Genetic and genomic testing have become effective tools because of scientific advancements. Both, however, have advantages and drawbacks. The present NBS efficiency for some genetic illnesses will be increased by the integrated analysis of metabolic and genetic data, allowing more affected people to obtain early diagnosis and treatment, which will improve their prognosis.

In addition, government programs and legislation also create a favorable environment to foster market growth. The newborn screening program was recommended by the WHO to safeguard the health of children globally. Under this program, numerous policies and initiatives have been taken by the Japan's Society of Obstetrics and Gynecology (JSOG), U.S. Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children (SACHDNC), UK (PEACH), and advocacy groups like the March of Dimes.

Moreover, in June 2022, Novartis entered into a strategic partnership with the American Society of Hematology to deal with sickle cell disease amongst newborns in an additional six African countries. ASH's Consortium on Newborn Screening in Africa (CONSA) will provide early intervention and screening programs at several institutions in countries such as Ghana, Liberia, Kenya, Nigeria, Tanzania, Uganda, and Zambia.

Additionally, more focus on innovation in the field of newborn screening is expected to drive market growth. For instance, in August 2022, Trivitron Healthcare launched a Centre of Excellence for newborn screening, genomics, molecular diagnostics, and metabolomics. Cancer markers based on ELISA, PCR, and IVD CE-approved kits for newborn screening will be manufactured at the facility.

Newborn Screening Market Report Highlights:

  • By test type, the dry blood spot test segment dominated the overall market for newborn screening in 2022. The collection of blood from a newborn's heel within 24-48 hours of birth on the screening card for diagnosis of over 50 conditions is termed a heel stick or dried blood spot (DBS) test
  • By technology, tandem mass spectrometry dominated the overall market in 2022 owing to high demand due to its cost-effectiveness, higher applicability, and technological upgrades
  • Asia Pacific accounted for the largest share of the market for newborn screening in 2022. Improving infrastructure and healthcare plans and the availability of new opportunities for expansion are expected to play a major role in driving regional market demand over the forecast period
  • Industry players are actively involved in strategic partnerships and mergers & acquisitions in order to ensure sustainability. For example, Trivitron Healthcare and Agilent Technologies have partnered to initiate collaboration in the area of high-precision in-vitro diagnostics based on the LC-MS/MS platform

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Test type segment
      • 1.1.1.2. Product segment
      • 1.1.1.3. Technology segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Test Type and Product Snapshot
  • 2.3. Technology Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Newborn Screening Market: Technology Analysis

  • 4.1. Newborn Screening Market: Technology Movement Analysis
  • 4.2. Tandem mass spectrometry
    • 4.2.1. Tandem mass spectrometry market, 2018 - 2030 (USD Million)
  • 4.3. Pulse oximetry
    • 4.3.1. Pulse oximetry market, 2018 - 2030 (USD Million)
  • 4.4. Enzyme based assay
    • 4.4.1. Enzyme based assays market, 2018 - 2030 (USD Million)
  • 4.5. DNA assays
    • 4.5.1. DNA assays market, 2018 - 2030 (USD Million)
  • 4.6. Electrophoresis
    • 4.6.1. Electrophoresis market, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Other technologies market, 2018 - 2030 (USD Million)

Chapter 5. Newborn Screening Market: Test Type Analysis

  • 5.1. Newborn Screening Market: Test Type Movement Analysis
  • 5.2. Dry blood spot test
    • 5.2.1. Dry blood spot test market, 2018 - 2030 (USD Million)
  • 5.3. CCHD
    • 5.3.1. CCHD test market, 2018 - 2030 (USD Million)
  • 5.4. Hearing screen
    • 5.4.1. Hearing screen test market, 2018 - 2030 (USD Million)

Chapter 6. Newborn Screening Market: Product Analysis

  • 6.1. Newborn Screening Market: Product Movement Analysis
  • 6.2. Instruments
    • 6.2.1. Instruments market, 2018 - 2030 (USD Million)
  • 6.3. Reagents
    • 6.3.1. Reagents market, 2018 - 2030 (USD Million)

Chapter 7. Newborn Screening Market: Regional Analysis

  • 7.1. Newborn Screening Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. North America Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Target Disease Prevalence
      • 7.2.2.3. Competitive Scenario
      • 7.2.2.4. Regulatory Framework
      • 7.2.2.5. U.S. Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Canada Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. UK Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Germany Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. France Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Italy Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Spain Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Denmark Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Sweden Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Norway Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. Japan Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. China Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. India Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Australia Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Thailand Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. South Korea Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Brazil Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Mexico Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Argentina Newborn Screening Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Regulatory Framework
      • 7.6.2.5. South Africa Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Saudi Arabia Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. UAE Newborn Screening Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Kuwait Newborn Screening Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Covidien Plc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. AB SCIEX
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Bio-Rad Laboratories
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Agilent Technologies
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Masimo Corporation
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Waters Corporation
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Natus Medical
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Trivitron Healthcare
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. GE Lifesciences
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. PerkinElmer Inc
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 4 Global newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 5 Global newborn screening market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America newborn screening market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 9 North America newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 10 U.S. newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 12 U.S. newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 13 Canada newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 15 Canada newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 16 Europe newborn screening market, by country, 2018 - 2030 (USD Million)
  • Table 17 Europe newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 18 Europe newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 19 Europe newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 20 UK newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 21 UK newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 22 UK newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 23 Germany newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 24 Germany newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 25 Germany newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 26 France newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 27 France newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 28 France newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 29 Italy newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 30 Italy newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 31 Italy newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 32 Spain newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 33 Spain newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 34 Spain newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 35 Denmark newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 36 Denmark newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 37 Denmark newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 38 Sweden newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 39 Sweden newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 40 Sweden newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 41 Norway newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 42 Norway newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Norway newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific newborn screening market, by country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 48 Japan newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 49 Japan newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 50 Japan newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 51 China newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 52 China newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 53 China newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 54 India newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 55 India newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 56 India newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 57 Australia newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 58 Australia newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 59 Australia newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 60 Thailand newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 61 Thailand newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Thailand newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 63 South Korea newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 64 South Korea newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 65 South Korea newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 66 Latin America newborn screening market, by country, 2018 - 2030 (USD Million)
  • Table 67 Latin America newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 68 Latin America newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 69 Latin America newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 70 Brazil newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 71 Brazil newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 72 Brazil newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 73 Mexico newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 74 Mexico newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 75 Mexico newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 76 Argentina newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 78 Argentina newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa newborn screening market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 83 South Africa newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 84 South Africa newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 85 South Africa newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 89 UAE newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 90 UAE newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 91 UAE newborn screening market, by test type, 2018 - 2030 (USD Million)
  • Table 92 Kuwait newborn screening market, by product, 2018 - 2030 (USD Million)
  • Table 93 Kuwait newborn screening market, by technology, 2018 - 2030 (USD Million)
  • Table 94 Kuwait newborn screening market, by test type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Newborn Screening market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global newborn screening market: Product movement analysis
  • Fig. 15 Global newborn screening market, for instruments, 2018 - 2030 (USD Million)
  • Fig. 16 Global newborn screening market, for reagents, 2018 - 2030 (USD Million)
  • Fig. 17 Global newborn screening market: Technology movement analysis
  • Fig. 18 Global newborn screening market, for tandem mass spectrometry, 2018 - 2030 (USD Million)
  • Fig. 19 Global newborn screening market, for pulse oximetry, 2018 - 2030 (USD Million)
  • Fig. 20 Global newborn screening market, for enzyme based assay technology, 2018 - 2030 (USD Million)
  • Fig. 21 Global newborn screening market, for DNA assays technology, 2018 - 2030 (USD Million)
  • Fig. 22 Global newborn screening market, for electrophoresis technology, 2018 - 2030 (USD Million)
  • Fig. 23 Global newborn screening market, for other technologies, 2018 - 2030 (USD Million)
  • Fig. 24 Global newborn screening market: Test type movement analysis
  • Fig. 25 Global newborn screening market, for Dry blood spot test, 2018 - 2030 (USD Million)
  • Fig. 26 Global newborn screening market, for CCHD, 2018 - 2030 (USD Million)
  • Fig. 27 Global newborn screening market, for Hearing Screen, 2018 - 2030 (USD Million)
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 Regional outlook, 2022 & 2030
  • Fig. 30 Global newborn screening market: Regional movement analysis
  • Fig. 31 North America newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 33 Canada newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 34 Europe newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 35 Germany newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 36 UK newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 37 France newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 38 Italy newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 39 Spain newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 42 Norway newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 44 Japan newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 45 China newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 46 India newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 47 Australia newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 52 Mexico newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 57 UAE newborn screening market, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait newborn screening market, 2018 - 2030 (USD Million)